As of 2024-09-19, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 22.0x | 13.6x |
| Forward P/E multiples | 20.8x - 32.7x | 23.0x |
| Fair Price | (12.50) - (12.91) | (11.62) |
| Upside | -182.0% - -184.6% | -176.2% |
| Date | EV/EBITDA |